Skip to main content

Table 2 Network meta-analysis results of efficacy outcomes

From: Comparative efficacy of treatments for patients with knee osteoarthritis: a network meta-analysis

Pain
 HA − 0.47 (− 1.6, 0.67) 0.46 (− 0.32, 1.25) − 0.56 (− 1.18, 0.07) 0.88 (− 0.17, 1.86) Stiffness
 1.4 (− 0.95, 3.65) Corticosteroid 0.93 (− 0.35, 2.22) − 0.09 (− 1.19, 1.02) 1.35 (− 0.16, 2.78)
 − 1.41 (-2.9, 0.03) − 2.82 (− 5.35, − 0.22) PRP − 1.02 (− 1.76, − 0.28) 0.41 (− 0.64, 1.39)
 1.66 (0.39, 2.89) 0.25 (− 1.99, 2.56) 3.07 (1.62, 4.53) Placebo 1.44 (0.3, 2.49)
 − 1.4 (-3.56, 0.84) − 2.81 (− 5.82, 0.4) 0 (− 2.11, 2.25) − 3.06 (− 5.36, − 0.63) HA + PRP
Physical function
 HA − 4.25 (− 12.88, 4.66) 8.37 (0.55, 16.49) − 6.17 (− 12.15, − 0.02) 13.32 (2.86, 23.91) Total
 2.62 (− 6.64, 11.74) Corticosteroid 12.62 (1.48, 23.72) − 1.94 (− 11.39, 7.41) 17.56 (4.07, 30.85)
 − 6.3 (− 12.98, 0.26) − 8.92 (-19.39, 1.74) PRP − 14.56 (− 22.02, − 7.19) 4.94 (− 5.43, 15.2)
 4.14 (− 1.19, 9.21) 1.51 (-7.66, 10.7) 10.43 (4.21, 16.58) Placebo 19.5 (8.4, 30.51)
 − 11.15 (− 19.83, − 2.62) − 13.78 (− 26.09, − 1.39) − 4.85 (− 13.35, 3.65) − 15.3 (− 24.42, − 6.06) HA + PRP
  1. HA hyaluronic acid, PRP platelet-rich plasma